{"transactions":[{"id":729142,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":35979,"kind":"person","name":"Slaoui Moncef","position":1,"cik":"0001712369","reported_name":"Slaoui Moncef","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-23T20:30:00.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":26061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option shall vest over 36 months, 1/3 of which will vest on June 17, 2027 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":26061,"derivative":{"exercise_price":52.11,"expiration_date":"2036-06-22","underlying":"Common Stock","underlying_shares":26061},"source":{"system":"sec-edgar","filing":"0001712369-26-000008","document":"wk-form4_1782246596.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000171236926000008/wk-form4_1782246596.xml","form_type":"4"}},{"id":737378,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":35979,"kind":"person","name":"Slaoui Moncef","position":1,"cik":"0001712369","reported_name":"Slaoui Moncef","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-06-15T21:00:59.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2026 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2026 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":7.3,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-26-000825","document":"e66580_4-slaoui.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712369/000119380526000825/e66580_4-slaoui.xml","form_type":"4"}},{"id":1114551,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":35979,"kind":"person","name":"Slaoui Moncef","position":1,"cik":"0001712369","reported_name":"Slaoui Moncef","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-06-12T00:01:48.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":12.54,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-25-000877","document":"e664623_4-slaoui.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712369/000119380525000877/e664623_4-slaoui.xml","form_type":"4"}},{"id":1471647,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":35979,"kind":"person","name":"Slaoui Moncef","position":1,"cik":"0001712369","reported_name":"Slaoui Moncef","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-22T01:30:44.000Z","date":"2024-06-19","kind":"grant","planned":false,"acquired":true,"shares":14794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares underlying the option vest monthly over a one year period from the date of grant. This represents the annual grant to the Reporting Person as a member of the Board, prorated based on the date the Reporting Person was appointed to the Board."}],"balance_after":14794,"derivative":{"exercise_price":25.96,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":14794},"source":{"system":"sec-edgar","filing":"0001193805-24-000836","document":"e663735_4-jing.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712369/000119380524000836/e663735_4-jing.xml","form_type":"4"}},{"id":1471646,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":35979,"kind":"person","name":"Slaoui Moncef","position":1,"cik":"0001712369","reported_name":"Slaoui Moncef","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-22T01:30:44.000Z","date":"2024-06-19","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the option vest monthly over a two year period from the date of grant. This represents the initial grant to the Reporting Person as a member of the Board of Directors."}],"balance_after":15000,"derivative":{"exercise_price":25.96,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-24-000836","document":"e663735_4-jing.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712369/000119380524000836/e663735_4-jing.xml","form_type":"4"}},{"id":3166510,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":35979,"kind":"person","name":"Slaoui Moncef","position":1,"cik":"0001712369","reported_name":"Slaoui Moncef","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-30T21:31:26.000Z","date":"2020-04-29","kind":"grant","acquired":true,"shares":18270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will become fully vested and exercisable on the earlier of April 29, 2021, or the next Annual Meeting of Stockholders, subject to the recipient's continued service."}],"balance_after":18270,"derivative":{"exercise_price":46.37,"expiration_date":"2030-04-29","underlying":"Common Stock","underlying_shares":18270},"source":{"system":"sec-edgar","filing":"0001127602-20-014877","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760220014877/form4.xml","form_type":"4"}},{"id":3476049,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":35979,"kind":"person","name":"Slaoui Moncef","position":1,"cik":"0001712369","reported_name":"Slaoui Moncef","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-28T20:32:27.000Z","date":"2019-06-27","kind":"grant","acquired":true,"shares":54660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will become fully vested and exercisable on the earlier of June 27, 2020, or the next Annual Meeting of Stockholders, subject to the recipient's continued service."}],"balance_after":54660,"derivative":{"exercise_price":14.34,"expiration_date":"2029-06-27","underlying":"Common Stock","underlying_shares":54660},"source":{"system":"sec-edgar","filing":"0001127602-19-023029","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760219023029/form4.xml","form_type":"4"}},{"id":4251891,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":35979,"kind":"person","name":"Slaoui Moncef","position":1,"cik":"0001712369","reported_name":"Slaoui Moncef","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-25T20:47:21.000Z","date":"2017-07-25","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 25, 2017 with respect to 38,000 shares of Common Stock, with 33% vesting on July 25, 2018 and the remaining 67% vesting in eight substantially equal quarterly installments thereafter."}],"balance_after":38000,"derivative":{"exercise_price":16.91,"expiration_date":"2027-07-24","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001209191-17-046188","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919117046188/doc4.xml","form_type":"4"}}]}